Sandoz Farmaceutica, Lda secures contract for Acquisition Of Natalizumab And Ustekinumab, From Lab Sandoz, For Ulsasi, For The Year 2026

Portugal, Feb. 17 -- Portugal based Sandoz Farmaceutica, Lda has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Natalizumab And Ustekinumab, From Lab Sandoz, For Ulsasi, For The Year 2026. The value of the contract is worth 2550440 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....